Literature DB >> 36255681

Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

Roger Sandhoff1, Konrad Sandhoff2.   

Abstract

Glycosphingolipids (GSLs) are a diverse group of membrane components occurring mainly on the surfaces of mammalian cells. They and their metabolites have a role in intercellular communication, serving as versatile biochemical signals (Kaltner et al, Biochem J 476(18):2623-2655, 2019) and in many cellular pathways. Anionic GSLs, the sialic acid containing gangliosides (GGs), are essential constituents of neuronal cell surfaces, whereas anionic sulfatides are key components of myelin and myelin forming oligodendrocytes. The stepwise biosynthetic pathways of GSLs occur at and lead along the membranes of organellar surfaces of the secretory pathway. After formation of the hydrophobic ceramide membrane anchor of GSLs at the ER, membrane-spanning glycosyltransferases (GTs) of the Golgi and Trans-Golgi network generate cell type-specific GSL patterns for cellular surfaces. GSLs of the cellular plasma membrane can reach intra-lysosomal, i.e. luminal, vesicles (ILVs) by endocytic pathways for degradation. Soluble glycoproteins, the glycosidases, lipid binding and transfer proteins and acid ceramidase are needed for the lysosomal catabolism of GSLs at ILV-membrane surfaces. Inherited mutations triggering a functional loss of glycosylated lysosomal hydrolases and lipid binding proteins involved in GSL degradation cause a primary lysosomal accumulation of their non-degradable GSL substrates in lysosomal storage diseases (LSDs). Lipid binding proteins, the SAPs, and the various lipids of the ILV-membranes regulate GSL catabolism, but also primary storage compounds such as sphingomyelin (SM), cholesterol (Chol.), or chondroitin sulfate can effectively inhibit catabolic lysosomal pathways of GSLs. This causes cascades of metabolic errors, accumulating secondary lysosomal GSL- and GG- storage that can trigger a complex pathology (Breiden and Sandhoff, Int J Mol Sci 21(7):2566, 2020).
© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Alzheimer; Catabolism; Degradation; Development; Endosomal pathway; Frontal lobe dementia; Ganglio-series; Ganglioside; Genetic disease; Glycolipid; Glycosphingolipid; Glycosyltransferase; Hydrolase; Intra-lysosomal luminal vesicle (ILV); Lysosomal storage disease (LSD); Lysosome; Membrane-surface; Metabolism; Neurodegenerative disease; Neuron; Organelle; Parkinson; Receptor; Secondary storage; Secretory pathway; Sphingolipid-binding protein (SAP); Sphingolipid-transfer protein; Topology

Mesh:

Substances:

Year:  2023        PMID: 36255681     DOI: 10.1007/978-3-031-12390-0_12

Source DB:  PubMed          Journal:  Adv Neurobiol


  356 in total

1.  GD3 synthase deletion alters retinal structure and impairs visual function in mice.

Authors:  Carla Andreia Abreu; Leandro Coelho Teixeira-Pinheiro; Rafael Lani-Louzada; Almir Jordão da Silva-Junior; Juliana F Vasques; Fernanda Gubert; Gabriel Nascimento-Dos-Santos; Ronaldo Mohana-Borges; Eduardo de Souza Matos; Pedro Moreno Pimentel-Coelho; Marcelo Felippe Santiago; Rosalia Mendez-Otero
Journal:  J Neurochem       Date:  2021-06-03       Impact factor: 5.372

2.  Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction.

Authors:  Irina Alecu; Andrea Tedeschi; Natascha Behler; Klaus Wunderling; Christian Lamberz; Mario A R Lauterbach; Anne Gaebler; Daniela Ernst; Paul P Van Veldhoven; Ashraf Al-Amoudi; Eicke Latz; Alaa Othman; Lars Kuerschner; Thorsten Hornemann; Frank Bradke; Christoph Thiele; Anke Penno
Journal:  J Lipid Res       Date:  2016-11-23       Impact factor: 5.922

3.  LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNFα-converting enzyme.

Authors:  Mohammad Ali; Ashish Saroha; Yael Pewzner-Jung; Anthony H Futerman
Journal:  FEBS Lett       Date:  2015-07-13       Impact factor: 4.124

4.  Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase.

Authors:  Misbaudeen Abdul-Hammed; Bernadette Breiden; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2017-01-26       Impact factor: 5.922

5.  Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.

Authors:  Hisako Akiyama; Susumu Kobayashi; Yoshio Hirabayashi; Kimiko Murakami-Murofushi
Journal:  Biochem Biophys Res Commun       Date:  2013-11-06       Impact factor: 3.575

6.  Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion.

Authors:  Misbaudeen Abdul-Hammed; Bernadette Breiden; Matthew A Adebayo; Jonathan O Babalola; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2010-02-23       Impact factor: 5.922

7.  Crystal structure of saposin B reveals a dimeric shell for lipid binding.

Authors:  Victoria E Ahn; Kym F Faull; Julian P Whitelegge; Arvan L Fluharty; Gilbert G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

Review 8.  Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function.

Authors:  Maria Laura Allende; Richard L Proia
Journal:  Glycoconj J       Date:  2014-10-29       Impact factor: 2.916

9.  α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies.

Authors:  Hazem Abdelkarim; Michael S Marshall; Giuseppe Scesa; Rachael A Smith; Emily Rue; Jeffrey Marshall; Vince Elackattu; Monika Stoskute; Yazan Issa; Marta Santos; Duc Nguyen; Zane Hauck; Richard van Breemen; Maria S Celej; Vadim Gaponenko; Ernesto R Bongarzone
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

10.  Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization.

Authors:  M Ali; J Fritsch; H Zigdon; Y Pewzner-Jung; S Schütze; A H Futerman
Journal:  Cell Death Dis       Date:  2013-11-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.